Dr. Nelson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030
Summary
- Blessie Nelson, MD is a Houston-based oncologist with a subspecialty in breast cancer. She completed her residency in Internal Medicine at the Sinai Hospital of Baltimore from 2016 to 2019, and her fellowship in Medical Oncology at the University of Texas Medical Branch Hospitals from 2019 to 2021. Dr. Nelson also holds a DMRT in Radiation Oncology from Christian Medical College. Currently, she serves as an Assistant Professor at the University of Texas M.D. Anderson Cancer Center, where she was previously a Research Fellow. Her published works have focused on various facets of oncology and her research has been cited multiple times in other publications.
Education & Training
University of Texas Medical Branch HospitalsFellowship, Medical Oncology, 2019 - 2021
Sinai Hospital of BaltimoreResidency, Internal Medicine, 2016 - 2019
Christian Medical College DMRT, Radiation Oncology , 2009 - 2011- Tribhuvan University Inst of MedicineClass of 2008
Certifications & Licensure
FL State Medical License 2024 - Present
AZ State Medical License 2024 - 2026
WA State Medical License 2024 - 2026
AL State Medical License 2024 - 2025
GA State Medical License 2024 - 2025
LA State Medical License 2024 - 2025
MS State Medical License 2024 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- Decentralized Clinical Trials in Early Drug Development-A Framework Proposal.Diogo J Silva, Blessie Elizabeth Nelson, Jordi Rodon
Journal of Immunotherapy and Precision Oncology. 2024-08-01 - 1 citationsRAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study.Blessie Elizabeth Nelson, Jason Roszik, Jibran Ahmed, Carmelia Maria Noia Barretto, Mirella Nardo
Molecular Cancer. 2024-03-26 - Predicting the Abscopal Phenomenon-Reply.Blessie Elizabeth Nelson, Vivek Subbiah
Molecular Cancer Therapeutics. 2024-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
